Unknown

Dataset Information

0

Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).

ABSTRACT: Interleukin 6 (IL-6) signaling plays a role in inflammation, cancer, and senescence. Here, we identified soluble IL-6 receptor (sIL-6R) as a member of the senescence-associated secretory phenotype (SASP). Senescence-associated sIL-6R upregulation was mediated by mammalian target of rapamycin (mTOR). sIL-6R was mainly generated by a disintegrin and metalloprotease 10 (ADAM10)-dependent ectodomain shedding to enable IL-6 trans-signaling. In vivo, heterozygous PTEN-knockout mice exhibited higher mTOR activity and increased sIL-6R levels. Moreover, aberrant EGF receptor (EGFR) activation triggered IL-6 synthesis. In analogy to senescence, EGFR-induced activation of mTOR also induced IL-6R expression and sIL-6R generation. Hence, mTOR activation reprograms IL-6 non-responder cells into IL-6 responder cells. Our data suggest that mTOR serves as a central molecular switch to facilitate cellular IL-6 classic and trans-signaling via IL-6R upregulation with direct implications for cellular senescence and tumor development.

SUBMITTER: Garbers C 

PROVIDER: S-EPMC3895430 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).

Garbers Christoph C   Kuck Fabian F   Aparicio-Siegmund Samadhi S   Konzak Kirstin K   Kessenbrock Mareike M   Sommerfeld Annika A   Häussinger Dieter D   Lang Philipp A PA   Brenner Dirk D   Mak Tak W TW   Rose-John Stefan S   Essmann Frank F   Schulze-Osthoff Klaus K   Piekorz Roland P RP   Scheller Jürgen J  

Cell cycle (Georgetown, Tex.) 20130918 21

Interleukin 6 (IL-6) signaling plays a role in inflammation, cancer, and senescence. Here, we identified soluble IL-6 receptor (sIL-6R) as a member of the senescence-associated secretory phenotype (SASP). Senescence-associated sIL-6R upregulation was mediated by mammalian target of rapamycin (mTOR). sIL-6R was mainly generated by a disintegrin and metalloprotease 10 (ADAM10)-dependent ectodomain shedding to enable IL-6 trans-signaling. In vivo, heterozygous PTEN-knockout mice exhibited higher mT  ...[more]

Similar Datasets

Unknown Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.
| S-EPMC2863215 | biostudies-literature
Unknown Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
| S-EPMC3880546 | biostudies-literature
Unknown Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1? Expression in Primary Mouse Cardiac Fibroblasts.
| S-EPMC6563870 | biostudies-literature
Unknown The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.
| S-EPMC3076631 | biostudies-literature
Unknown The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior.
| S-EPMC7532208 | biostudies-literature
Unknown Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1.
| S-EPMC3099723 | biostudies-literature
Unknown PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
| S-EPMC3600508 | biostudies-other
Unknown Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.
| S-EPMC2789206 | biostudies-literature
Unknown Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation.
| S-EPMC2827328 | biostudies-literature
Unknown Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy.
| S-EPMC4416842 | biostudies-literature